Literature DB >> 22873050

[Pioglitazone, an activator of PPAR-gamma, reduces the expression of kB nuclear factor and inhibits apoptosis in mononuclear cells of peripheral blood in vitro].

N L Kutsenko, L E Vesnina, I P Kaĭdashev.   

Abstract

In order to examine the impact of PPAR-gamma activator on the expression of kB nuclear transcription factor and apoptosis, the peripheral blood mononuclear cells (PBMC) were incubated with pioglitazone at concentrations 10, 30 and 100 MM. Expression of NF-kB in CD64+ cells was evaluated by flow cytometry using monoclonal antibodies. The development of apoptosis was evaluated using annexin V and propidium iodide. Activation of PPAR-y resulted in a reduction of the number of CD64+ cells and expression of the maximum levels of these receptors. We also obesrved a dose-dependent decrease of NF-kB concentration in PBMC suspension and in CD64+ cells. While analyzing the apoptosis, the reduction of apoptotic cells (reduction of AnV+PI+ cells) has been observed. The results obtained allow to prove that PPAR-gamma activation participates in the PBMC apoptosis regulation and in the expression of transcriptional factor NF-kB. Our results indicate for the involvement of PPAR-gamma in the regulation of NF-kB activity which plays one of the most significant roles in the inflammation realization, oncogenesis, and so on.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873050

Source DB:  PubMed          Journal:  Fiziol Zh        ISSN: 2522-9028


  5 in total

1.  RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.

Authors:  Fang Chen; Arijit Ghosh; Mei Hu; Yan Long; Hongbin Sun; Lingyi Kong; Hao Hong; Susu Tang
Journal:  Neurotox Res       Date:  2017-09-04       Impact factor: 3.911

Review 2.  Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis.

Authors:  Meysam Gachpazan; Sadra Habbibirad; Hoda Kashani; Tannaz Jamialahmadi; Hamid Reza Rahimi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes.

Authors:  Maurício T Nascimento; Ravena S O Cordeiro; Cayo Abreu; Camila P Santos; Fábio Peixoto; Gabriela A Duarte; Thiago Cardoso; Camila I de Oliveira; Edgar M Carvalho; Lucas P Carvalho
Journal:  Front Cell Infect Microbiol       Date:  2022-07-14       Impact factor: 6.073

4.  The use of Latin terminology in medical case reports: quantitative, structural, and thematic analysis.

Authors:  Yuliia V Lysanets; Olena M Bieliaieva
Journal:  J Med Case Rep       Date:  2018-02-23

5.  PPAR-Gamma Agonist Pioglitazone Reduced CD68+ but Not CD163+ Macrophage Dermal Infiltration in Obese Psoriatic Patients.

Authors:  Ya O Yemchenko; V I Shynkevych; K Ye Ishcheikin; I P Kaidashev
Journal:  PPAR Res       Date:  2020-05-01       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.